Patients With Hematologic Malignancies May Be Less Likely To Have Seroprotection Against Measles And Mumps, Research Suggests

Infectious Disease Advisor (11/10, Masoud) reports younger “patients with hematologic malignancies are less likely to have seroprotection against measles and mumps.” The findings were presented at IDWeek.